会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MICRONEEDLE DEVICES AND METHODS
    • MICRONEEDLE设备和方法
    • WO2012122163A1
    • 2012-09-13
    • PCT/US2012/027858
    • 2012-03-06
    • 3M INNOVATIVE PROPERTIES COMPANYZHANG, YingHANSEN, Kristen J.DETERMAN, Amy S.
    • ZHANG, YingHANSEN, Kristen J.DETERMAN, Amy S.
    • A61K9/00A61M37/00
    • A61K9/0021A61M37/0015A61M2037/0023A61M2037/0046A61M2037/0061
    • A medical device, comprising: an array of microneedles, and a coating disposed on the microneedles, wherein the coating comprises: a local anesthetic selected from the group consisting of lidocaine, prilocaine, and a combination thereof; and a local anesthetic dose-extending component selected from the group consisting of tetracaine, ropivacaine, bupivacaine, procaine and a combination thereof; wherein the local anesthetic is present in an amount of at least 1 wt-% based upon total weight of solids in the coating, and wherein the local anesthetic and dose-extending component are in a non-eutectic weight ratio; a medical device, comprising an array of dissolvable microneedles, the microneedles comprising: a dissolvable matrix material; at least 1 wt-% of a local anesthetic selected from the group consisting of lidocaine, prilocaine, and a combination thereof; and a local anesthetic dose-extending component selected from the group consisting of tetracaine, ropivacaine, bupivacaine, procaine and a combination thereof; wherein the local anesthetic and dose-extending component are in a non-eutectic weight ratio, and wherein wt-% is based upon total weight of solids in all portions of the dissolvable microneedles which contain the local anesthetic; a method of extending a topically delivered local anesthetic dose in mammalian tissue using the devices; and methods of making the devices are provided.
    • 一种医疗装置,包括:微针阵列和设置在所述微针上的涂层,其中所述涂层包括:选自利多卡因,丙胺卡因及其组合的局部麻醉剂; 以及选自丁卡因,罗哌卡因,布比卡因,普鲁卡因及其组合的局部麻醉剂剂量延伸组分; 其中所述局部麻醉剂以基于所述涂层中固体总重量的至少1重量%的量存在,并且其中所述局部麻醉剂和剂量延伸组分为非共晶重量比; 包括可溶性微针阵列的医疗装置,所述微针包括:可溶性基质材料; 至少1重量%的选自利多卡因,丙胺卡因及其组合的局部麻醉剂; 以及选自丁卡因,罗哌卡因,布比卡因,普鲁卡因及其组合的局部麻醉剂剂量延伸组分; 其中所述局部麻醉剂和剂量延伸组分为非共晶重量比,并且其中wt%基于含有所述局部麻醉剂的可溶性微针的所有部分中固体的总重量; 使用所述装置延长哺乳动物组织中局部递送的局部麻醉剂剂量的方法; 并提供制造设备的方法。
    • 2. 发明申请
    • MICRONEEDLE DEVICES AND METHODS
    • MICRONEEDLE设备和方法
    • WO2012122162A1
    • 2012-09-13
    • PCT/US2012/027857
    • 2012-03-06
    • 3M INNOVATIVE PROPERTIES COMPANYZHANG, YingHANSEN, Kristen J.DETERMAN, Amy S.
    • ZHANG, YingHANSEN, Kristen J.DETERMAN, Amy S.
    • A61K9/00A61M37/00
    • A61K9/0021A61M37/0015A61M2037/0023A61M2037/0046A61M2037/0061
    • A medical device, comprising: an array of microneedles, and a coating disposed on the microneedles, wherein the coating comprises: a local anesthetic selected from the group consisting of lidocaine, prilocaine, and a combination thereof; and a local anesthetic dose-extending component selected from the group consisting of alpha 1 adrenergic agonists, alpha 2 adrenergic agonists, and a combination thereof; wherein the local anesthetic is present in an amount of at least 1 wt-% based upon total weight of solids in the coating, and wherein the dose-extending component/local anesthetic weight ratio is at least 0.0001; a medical device, comprising an array of dissolvable microneedles, the microneedles comprising: a dissolvable matrix material; at least 1 wt-% of a local anesthetic selected from the group consisting of lidocaine, prilocaine, and a combination thereof; and a local anesthetic dose-extending component selected from the group consisting of alpha 1 adrenergic agonists, alpha 2 adrenergic agonists, and a combination thereof; wherein the dose-extending component/local anesthetic weight ratio is at least 0.0001, and wherein wt-% is based upon total weight of solids in all portions of the dissolvable microneedles which contain the local anesthetic; a method of extending a topically delivered local anesthetic dose in mammalian tissue using the devices; and methods of making the devices are provided.
    • 一种医疗装置,包括:微针阵列和设置在所述微针上的涂层,其中所述涂层包括:选自利多卡因,丙胺卡因及其组合的局部麻醉剂; 以及选自α1肾上腺素能激动剂,α2肾上腺素能激动剂及其组合的局部麻醉剂剂量延伸组分; 其中所述局部麻醉剂以基于所述包衣中固体总重量的至少1重量%的量存在,并且其中所述剂量延长组分/局部麻醉剂重量比至少为0.0001; 包括可溶性微针阵列的医疗装置,所述微针包括:可溶性基质材料; 至少1重量%的选自利多卡因,丙胺卡因及其组合的局部麻醉剂; 以及选自α1肾上腺素能激动剂,α2肾上腺素能激动剂及其组合的局部麻醉剂剂量延伸组分; 其中所述剂量延伸组分/局部麻醉重量比为至少0.0001,并且其中wt%基于含有所述局部麻醉剂的可溶性微针的所有部分中固体的总重量; 使用所述装置延长哺乳动物组织中局部递送的局部麻醉剂剂量的方法; 并提供制造设备的方法。
    • 8. 发明公开
    • MICRONEEDLE DEVICES AND METHODS
    • MICRONEEDLE设备和方法
    • EP2683358A1
    • 2014-01-15
    • EP12709231.0
    • 2012-03-06
    • 3M Innovative Properties Company
    • ZHANG, YingHANSEN, Kristen J.DETERMAN, Amy S.
    • A61K9/00A61M37/00
    • A61K9/0021A61M37/0015A61M2037/0023A61M2037/0046A61M2037/0061
    • A medical device, comprising: an array of microneedles, and a coating disposed on the microneedles, wherein the coating comprises: a local anesthetic selected from the group consisting of lidocaine, prilocaine, and a combination thereof; and a local anesthetic dose-extending component selected from the group consisting of alpha 1 adrenergic agonists, alpha 2 adrenergic agonists, and a combination thereof; wherein the local anesthetic is present in an amount of at least 1 wt-% based upon total weight of solids in the coating, and wherein the dose-extending component/local anesthetic weight ratio is at least 0.0001; a medical device, comprising an array of dissolvable microneedles, the microneedles comprising: a dissolvable matrix material; at least 1 wt-% of a local anesthetic selected from the group consisting of lidocaine, prilocaine, and a combination thereof; and a local anesthetic dose-extending component selected from the group consisting of alpha 1 adrenergic agonists, alpha 2 adrenergic agonists, and a combination thereof; wherein the dose-extending component/local anesthetic weight ratio is at least 0.0001, and wherein wt-% is based upon total weight of solids in all portions of the dissolvable microneedles which contain the local anesthetic; a method of extending a topically delivered local anesthetic dose in mammalian tissue using the devices; and methods of making the devices are provided.
    • 1。一种医疗装置,包括:微针阵列和布置在所述微针上的涂层,其中所述涂层包括:选自利多卡因,丙胺卡因及其组合的局部麻醉剂; 和选自α1肾上腺素能激动剂,α2肾上腺素能激动剂及其组合的局部麻醉剂量延长组分; 其中所述局部麻醉剂以基于涂层中固体总重量的至少1重量%的量存在,并且其中剂量增加组分/局部麻醉剂重量比至少为0.0001; 包括可溶解微针阵列的医疗装置,所述微针包括:可溶解基质材料; 至少1重量%的选自利多卡因,丙胺卡因及其组合的局部麻醉剂; 和选自α1肾上腺素能激动剂,α2肾上腺素能激动剂及其组合的局部麻醉剂量延长组分; 其中所述剂量延长组分/局部麻醉剂重量比至少为0.0001,并且其中wt-%基于含有所述局部麻醉剂的所述可溶解微针的所有部分中的固体总重量; 使用所述装置在哺乳动物组织中延长局部递送的局部麻醉剂量的方法; 并提供了制造这些装置的方法。